September 21, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Abby Adams
| Re: | Minerva Neurosciences, Inc. |
Registration Statement on Form S-3
File No. 333- 267424
Acceleration Request
Requested Date: September 23, 2022
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333- 267424) (the “Registration Statement”) to become effective on Friday, September 23, 2022 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Ryan S. Sansom of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335.
| Very truly yours, | ||
| Minerva Neurosciences, Inc. | ||
| By: | /s/ Frederick Ahlholm | |
| Frederick Ahlholm | ||
| Chief Financial Officer | ||
| cc: | Remy Luthringer, Chief Executive Officer, Minerva Neurosciences, Inc. |
Geoff Race, President, Minerva Neurosciences, Inc.
Marc Recht, Cooley LLP
Ryan S. Sansom, Cooley LLP